Le Lézard
Classified in: Health, Business
Subject: TNM

Maryland Vision Institute Acquired By Premier Mid-Atlantic Ophthalmology Group


FREDERICK, Md., March 20, 2018 /PRNewswire-PRWeb/ -- Maryland Vision Institute, a leading provider of ophthalmology services in Western Maryland and West Virginia, has been acquired by the group that owns Chesapeake Eye Care and Laser Center and Whitten Laser Eye. The acquisition further expands this group of leading ophthalmology practices in the mid-Atlantic known for providing patients with superior outcomes and outstanding patient care.

Maryland Vision Institute operates locations in Hagerstown, Frederick and Hancock, Maryland, and one location in Martinsburg, West Virginia. Led by Dr. Augustus "Gus" Stern and Dr. Sidney Chang, Maryland Vision Institute is dedicated to providing convenient access to world-class vision care.

"We are honored to join a team of outstanding physicians and clinical practitioners ? including Chesapeake Eye Care Company and Whitten Laser Eye ? to deliver the highest quality vision care and offer the state-of-the-art technology that is the hallmark of our ever-changing landscape of healthcare," said Dr. Stern.

With a national reputation for pioneering innovative vision solutions, Maryland Vision Institute attributes its success to its passionate, dedicated team of experts. Offering patients an exceptional experience and delivering the best visual outcomes are paramount to the success of their practice.

"As we continue to build a leading medical and surgical ophthalmology group in the mid-Atlantic region, Maryland Vision Institute is a perfect addition to our growing network, with its highly skilled physicians, multispecialty practice and efficient business operations," said Michael Dunn, CEO of Chesapeake Eye Care Company. "We are committed to expanding patient access to high-quality clinical eye care by seeking the most qualified, experienced practices to join our group of partners."

The acquisition of Maryland Vision Institute demonstrates the group's commitment to recruiting top-performing doctors and high-quality ophthalmology practices where it has a growing network of practice locations and surgery centers: the Maryland, Virginia, Washington, DC, and West Virginia markets.

Chesapeake Eye Care Company is backed by Centre Partners, a leading middle-market private equity firm founded in 1986 with offices in New York and Los Angeles that is focused on the consumer and health care sectors. Since its inception, Centre Partners has invested more than $2 billion of equity capital in 75+ transactions and provides management teams with access to an extended network of experienced executives with proven success in business operations.

 

SOURCE Maryland Vision Institute


These press releases may also interest you

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 11:00
PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam's appointment follows an extensive...

at 11:00
MasterControl, a leading provider of quality management and manufacturing execution software for life sciences, announced it has been recognized by the Imapac 2024 Asia-Pacific Biopharma Excellence Awards in the "Best Bioprocessing Supplier:...

at 10:36
Senstar Technologies Corporation , a leading international provider of comprehensive physical, video and access control security products and solutions, announced today that its Annual Report on Form 20-F for the year ended December 31, 2023 has been...

at 10:33
The report titled "Peptide Therapeutics Market by Technology (Hybrid Phase, Liquid Phase, Solid Phase), Drug Class (Adrenocorticotropic Hormone, Calcitonin, Insulin), Route of Administration, Application, End User, Manufacturing Type - Global...



News published on and distributed by: